Showing 3591-3600 of 5621 results for "".
- Eyedaptic Unveils AI-Powered Visual Assistant for People with Retinal Disordershttps://modernod.com/news/eyedaptic-unveils-eye6-with-ivy-ai-powered-visual-assistant-for-people-with-retinal-disorders/2482385/Eyedaptic unveiled the EYE6 with Ivy, a wearable vision aid designed to enhance vision and provide an AI-powered visual assistant. The EYE6 is the next generation of Eyedaptic’s smart glasses, which includes Ivy, an interactive visual assistant to help and
- Enrollment Begins for Ocular Therapeutix’s Axpaxli Phase 3 SOL-R Wet AMD Studyhttps://modernod.com/news/ocular-therapeutixs-axpaxli-phase-3-sol-r-wet-amd-study-begins-enrollment/2482382/Ocular Therapeutix announced that the first patients have been enrolled in the phase 3 SOL-R clinical trial evaluating repeat dosing of Axpaxli (axitinib intravitreal implant, also known as OTX-TKI) for the treatment of patients with wet age-related macular degeneration (wet AMD). Accor
- Topcon Launches IS-6500 Ophthalmic Instrument Standhttps://modernod.com/news/topcons-is-6500-ophthalmic-instrument-stand-launched/2482381/Topcon Healthcare announced the launch of the IS-6500 digital instrument stand in the United States, Latin America, and Canada. The IS-6500 stand joins Topcon’s portfolio of ergonomic devices for eye exams. According to the company, the IS-6500 stand incorporates specialized
- Johnson & Johnson Invests in Refractive Technology Start-Up TECLenshttps://modernod.com/news/johnson-johnson-invests-in-refractive-technology-start-up-teclens/2482372/Johnson & Johnson closed a transaction to co-lead the Series A funding of TECLens, a start-up developing a nonincisional refractive correction procedure that leverages corneal cross-linking (CXL) to reshape the cornea. Financial terms of the deal were not disclo
- Oertli Receives FDA 510(k) Clearance for Faros Surgical Systemhttps://modernod.com/news/oertli-instrumente-ag-achieves-milestone-with-fda-510k-clearance-for-faros-surgical-system/2482371/Oertli Instrumente announced it has received FDA 510(k) clearance for the Faros anterior cataract surgery system. According to a company news release, the Faros system offers a compact design and rapid operational readiness, requiring minimal space in operating rooms. It
- AbbVie Launches Refresh Tears PF and Refresh Relieva PF Xtrahttps://modernod.com/news/abbvie-launches-refresh-tears-pf-and-refresh-relieva-pf-xtra/2482369/AbbVie has introduced two new preservative-free (PF) lubricant eye drop products─Refresh Tears PF and Refresh Relieva PF Xtra. According to AbbVie, the new products contain several new features: Multidose Bottle Design: The bottles
- Bausch + Lomb Acquires Diagnostic Company Trukera Medicalhttps://modernod.com/news/bausch-lomb-acquires-diagnostic-company-trukera-medical/2482368/Bausch + Lomb announced it has acquired US-based privately held ophthalmic medical diagnostic company Trukera Medical. Financial terms of the deal were not disclosed. An affiliate of B+L acquired Trukera from its private equity owner, AccelMed Partners, and other shareholders. 
- Vabysmo Showed Extended Durability, Continued Efficacy and a Consistent Safety Profile in Long-Term DME Studyhttps://modernod.com/news/vabysmo-showed-extended-durability-continued-efficacy-and-a-consistent-safety-profile-in-long-term-dme-study/2482363/At the American Society of Retina Specialists (ASRS) 2024 Annual Meeting in Stockholm, Sweden, Genentech announced new, 4-year data from the RHONE-X extension study. The study met all primary endpoints, showing that Vabysmo (faricimab-svoa) was well tolerated in people with diabetic mac
- EssilorLuxottica Acquires Majority Stake in Heidelberg Engineeringhttps://modernod.com/news/essilorluxottica-acquires-majority-stake-in-heidelberg-engineering/2482362/Optical industry giant EssilorLuxottica announced it has reached a deal to acquire an 80% stake in Germany-based Heidelberg Engineering. Financial terms of the deal were not disclosed. Founded by Dr. Gerhard Zinser and Christoph Schoess in 1990, Heidelberg is a prov
- Heidelberg Engineering Introduces Faster OCT Angiography with Spectralis Shift Technologyhttps://modernod.com/news/heidelberg-engineering-introduces-faster-oct-angiography-with-spectralis-shift-technology/2482359/Heidelberg Engineering has received FDA clearance of the Spectralis OCTA Module with Shift technology, which is designed to reduce acquisition time by 50%.[1] The preset OCTA speed of 125 kHz helps streamline workflow, enhance clinical e